Patent details

EP1773869 Title: MACROCYCLIC MODULATORS OF THE GHRELIN RECEPTOR

Basic Information

Publication number:
EP1773869
PCT Application Number:
PCT/US/2005/020857
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP057851859
PCT Publication Number:
WO/2006/009674
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
MACROCYCLIC MODULATORS OF THE GHRELIN RECEPTOR
French Title of Invention:
MODULATEURS MACROCYCLIQUES DU RECEPTEUR A GHRELINE
German Title of Invention:
MAKROZYKLISCHE MODULATOREN DES GHRELIN-REZEPTORS
SPC Number:

Dates

Filing date:
13/06/2005
Grant date:
22/08/2012
EP Publication Date:
22/08/2012
PCT Publication Date:
26/01/2006
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
18/04/2007
EP B1 Publication Date:
22/08/2012
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
13/06/2013
Expiration date:
13/06/2025
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
13/06/2005
 
 

Name:
Tranzyme Pharma Inc.
Address:
3001 12th Avenue Nord, Sherbrooke, QC J1H 5N4, Canada (CA)

Inventor

1

Name:
HOVEYDA Hamid
Address:
Canada (CA)

2

Name:
RAMASESHAN Mahesh
Address:
United States (US)

3

Name:
PETERSON Mark
Address:
Canada (CA)

4

Name:
FRASER Graeme
Address:
Canada (CA)

Priority

1

Priority Number:
872142
Priority Date:
18/06/2004
Priority Country:
United States (US)

2

Priority Number:
621642 P
Priority Date:
26/10/2004
Priority Country:
United States (US)

3

Priority Number:
622005 P
Priority Date:
27/10/2004
Priority Country:
United States (US)

4

Priority Number:
642271 P
Priority Date:
07/01/2005
Priority Country:
United States (US)

5

Priority Number:
149731
Priority Date:
10/06/2005
Priority Country:
United States (US)

Classification

Main IPC Class:
C07K 5/08;
Filing date Document type Number of pages